HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel mutation of the alpha2-globin causing alpha(+)-thalassemia: Hb Plasencia [alpha125(H8)Leu--Arg (alpha2).

Abstract
We describe, in a Spanish family with moderate microcytosis and hypochromia, a novel nondeletional alpha-thalassemia (thal) mutation localized on the alpha2-globin gene. DNA sequencing revealed a point mutation at codon 125 (CTG --> CGG) in the heterozygous state, that was confirmed by restriction analysis. The resulting variant, which causes a nondeletional alpha-thal, was named Hb Plasencia [alpha125(H8)Leu --> Arg (alpha2)] after the place of residence of the affected family.
AuthorsGuillermo Martin, Ana Villegas, Fernando Ataulfo González, Paloma Ropero, Ricardo Hojas, Marta Polo, Marta Mateo, Maria Salvador, Celina Benavente
JournalHemoglobin (Hemoglobin) Vol. 29 Issue 2 Pg. 113-7 ( 2005) ISSN: 0363-0269 [Print] England
PMID15921163 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hemoglobins, Abnormal
  • Globins
Topics
  • Adult
  • Aged
  • Amino Acid Substitution
  • DNA Mutational Analysis
  • Family Health
  • Female
  • Globins (genetics)
  • Hemoglobins, Abnormal (genetics)
  • Humans
  • Male
  • Middle Aged
  • Point Mutation (genetics)
  • Spain
  • alpha-Thalassemia (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: